Other Medical Devices - Chile

  • Chile
  • In Chile, the market for Other Medical Devices market is anticipated to achieve a revenue of US$1.01bn in 2024.
  • Looking ahead, it is expected that the revenue will experience a compound annual growth rate (CAGR 2024-2028) of 6.51%, leading to a market volume of US$1.30bn by 2028.
  • When compared globally, the United States is forecasted to generate the highest revenue, amounting to US$73,490.00m in 2024.
  • Chile's Other Medical Devices market is experiencing a surge in demand due to the country's growing elderly population and increasing healthcare spending.

Key regions: United Kingdom, Netherlands, Japan, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Medical Devices market in Chile has been experiencing significant growth in recent years.

Customer preferences:
Customers in Chile are increasingly seeking out innovative and technologically advanced medical devices. They are looking for products that offer greater accuracy, efficiency, and convenience in diagnosing and treating various medical conditions. Additionally, there is a growing demand for devices that are portable and can be used at home, allowing patients to monitor their health and receive treatment in a more comfortable and convenient setting.

Trends in the market:
One of the key trends in the Other Medical Devices market in Chile is the increasing adoption of digital health technologies. This includes wearable devices, remote patient monitoring systems, and telemedicine solutions. These technologies allow healthcare providers to remotely monitor patients, provide virtual consultations, and gather real-time data for more accurate diagnoses and personalized treatment plans. The COVID-19 pandemic has further accelerated the adoption of telemedicine and remote monitoring solutions, as they enable patients to receive medical care without having to visit a healthcare facility. Another trend in the market is the rising demand for minimally invasive medical devices. These devices offer numerous benefits, including reduced scarring, shorter recovery times, and lower risk of complications compared to traditional surgical procedures. This has led to an increased use of devices such as laparoscopic instruments, catheters, and endoscopic tools in various medical specialties.

Local special circumstances:
Chile has a well-developed healthcare system with a high level of access to medical services. The country has a strong focus on healthcare innovation and invests heavily in research and development. This has created a favorable environment for the adoption of new medical technologies and devices. Additionally, the Chilean government has implemented various policies and initiatives to promote the use of digital health technologies and improve healthcare outcomes.

Underlying macroeconomic factors:
Chile has a stable economy with a growing middle class and an aging population. As the population ages, there is an increasing need for medical devices to manage chronic conditions and age-related health issues. Furthermore, the government has been investing in healthcare infrastructure and increasing healthcare spending, which has contributed to the growth of the Other Medical Devices market in Chile. In conclusion, the Other Medical Devices market in Chile is experiencing growth due to customer preferences for innovative and technologically advanced devices, the adoption of digital health technologies, and the increasing demand for minimally invasive procedures. The local special circumstances, such as a well-developed healthcare system and government support for healthcare innovation, further contribute to the market's growth. Additionally, underlying macroeconomic factors, such as a growing middle class and an aging population, drive the demand for medical devices in Chile.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)